The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease
Open accessAbstract
Background/Aims: In this retrospective study we aimed to compare the effect of tranexamic acid (TXA) vs etamsylate, two hemostatic agents, on hematuria duration in autosomal dominant polycystic kidney disease (ADPKD) patients with persistent gross hematuria. Methods: This is a retrospective study of 40 patients with ADPKD and macroscopic hematuria. 20 patients receiving TXA and snake venom blood clotting enzyme injection were compared with 20 matched patients receiving etamsylate and snake venom blood clotting enzyme injection. The primary outcome was hematuria duration and the secondary outcomes were blood transfusion requirements and adverse events. Results: The hematuria duration was shorter in the TXA group compared with the etamsylate group (4[3-5] d vs 7[6-10] d, P<0.001). The volume of blood transfusion tended to be less in the TXA group than in the etamsylate group (300±115 ml vs 486±195 ml, P=0.12), and the number of patients needing a blood transfusion also tended to be lower [20% (4/20) vs 35% (7/20), P=0.29]. TXA and etamsylate were equally well tolerated and no serious adverse events were observed in both groups. Conclusions: Our study indicates that TXA treatment was more effective than etamsylate in stopping bleeding in ADPKD patients with persistent gross hematuria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells
Nauli, S. M., Alenghat, F. J., Luo, Y., Williams, E., Vassilev, P., Li, X., Elia, A. E. H., Lu, W., Brown, E. M., Quinn, S. J., et al. (2003) · Nature Genetics · doi:10.1038/ng1076 · Cited by 2,057
Self-citationPKD2 , a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein
Mochizuki, T., Wu, G., Hayashi, T., Xenophontos, S. L., Veldhuisen, B., Saris, J. J., Reynolds, D. M., Cai, Y., Gabow, P. A., Pierides, A., et al. (1996) · Science · doi:10.1126/science.272.5266.1339 · Cited by 1,406
Tranexamic Acid: A Review of its Use in Surgery and Other Indications
Dunn, C. J., & Goa, K. L. (1999) · Drugs · doi:10.2165/00003495-199957060-00017 · Cited by 1,003
Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis
Ker, K., Edwards, P., Perel, P., Shakur, H., & Roberts, I. (2012) · BMJ · doi:10.1136/bmj.e3054 · Cited by 997
Hughes, J., Ward, C. J., Peral, B., Aspinwall, R., Clark, K., San Millán, J. L., Gamble, V., & Harris, P. C. (1995) · Nature Genetics · doi:10.1038/ng0695-151 · Cited by 910
Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents
Hanaoka, K., Qian, F., Boletta, A., Bhunia, A. K., Piontek, K., Tsiokas, L., Sukhatme, V. P., Guggino, W. B., & Germino, G. G. (2000) · Nature · doi:10.1038/35050128 · Cited by 818
Unified Criteria for Ultrasonographic Diagnosis of ADPKD
Pei, Y., Obaji, J., Dupuis, A., Paterson, A. D., Magistroni, R., Dicks, E., Parfrey, P., Cramer, B., Coto, E., Torra, R., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050507 · Cited by 762
Polycystin-2 is an intracellular calcium release channel
Koulen, P., Cai, Y., Geng, L., Maeda, Y., Nishimura, S., Witzgall, R., Ehrlich, B. E., & Somlo, S. (2002) · Nature Cell Biology · doi:10.1038/ncb754 · Cited by 706
Tranexamic Acid: A Review of its Use in the Treatment of Hyperfibrinolysis
McCormack, P. L. (2012) · Drugs · doi:10.2165/11209070-000000000-00000 · Cited by 640
Comparison of phenotypes of polycystic kidney disease types 1 and 2
Hateboer, N., v Dijk, M. A., Bogdanova, N., Coto, E., Saggar-Malik, A. K., Millan, J. L. S., Torra, R., Breuning, M., & Ravine, D. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03495-3 · Cited by 628
Polycystic kidney disease: The complete structure of the PKD1 gene and its protein
The International Polycystic Kidney Disease Consortium (1995) · Cell · doi:10.1016/0092-8674(95)90339-9 · Cited by 625
Qian, F., Watnick, T. J., Onuchic, L. F., & Germino, G. G. (1996) · Cell · doi:10.1016/s0092-8674(00)81793-6 · Cited by 615
Genetics and Pathogenesis of Polycystic Kidney Disease
Igarashi, P., & Somlo, S. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000028643.17901.42 · Cited by 593
Somatic Inactivation of Pkd2 Results in Polycystic Kidney Disease
Wu, G., D'Agati, V., Cai, Y., Markowitz, G., Park, J. H., Reynolds, D. M., Maeda, Y., Le, T. C., Hou, H., Kucherlapati, R., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81570-6 · Cited by 570
Ravine, D., Sheffield, L., Danks, D. M., Gibson, R. N., Walker, R. G., & Kincaid-Smith, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92026-5 · Cited by 564
Mannucci, P. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390407 · Cited by 557
Comprehensive Molecular Diagnostics in Autosomal Dominant Polycystic Kidney Disease
Rossetti, S., Consugar, M. B., Chapman, A. B., Torres, V. E., Guay-Woodford, L. M., Grantham, J. J., Bennett, W. M., Meyers, C. M., Walker, D. L., Bae, K., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121387 · Cited by 439
The Diagnosis and Prognosis of Autosomal Dominant Polycystic Kidney Disease
Parfrey, P. S., Bear, J. C., Morgan, J., Cramer, B. C., McManamon, P. J., Gault, M. H., Churchill, D. N., Singh, M., Hewitt, R., Somlo, S., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010183231601 · Cited by 356
Genetic Heterogeneity of Polycystic Kidney Disease in Europe1
Peters, D. J. M., & Sandkuijl, L. A. (2015) · Contributions to Nephrology · doi:10.1159/000421651 · Cited by 282
Autosomal dominant polycystic kidney disease: the changing face of clinical management
Ong, A. C. M., Devuyst, O., Knebelmann, B., & Walz, G. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60907-2 · Cited by 280
Evidence for a third genetic locus for autosomal dominant polycystic kidney disease
Daoust, M. C., Reynolds, D. M., Bichet, D. G., & Somlo, S. (1995) · Genomics · doi:10.1016/0888-7543(95)80020-m · Cited by 272
Harris, P. C., Bae, K. T., Rossetti, S., Torres, V. E., Grantham, J. J., Chapman, A. B., Guay-Woodford, L. M., King, B. F., Wetzel, L. H., Baumgarten, D. A., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080835 · Cited by 271
Mutation Analysis of the Entire PKD1 Gene: Genetic and Diagnostic Implications
Rossetti, S., Strmecki, L., Gamble, V., Burton, S., Sneddon, V., Peral, B., Roy, S., Bakkaloglu, A., Komel, R., Winearls, C. G., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/316939 · Cited by 232
Lu, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.21.2385 · Cited by 191
Phenotype and genotype heterogeneity in autosomal dominant polycystic kidney disease
Ravine, D., Forrest, S. M., Sheffield, L. J., Danks, D. M., Walker, R. G., Kincaid-Smith, P., Gibson, R. N., Richards, R. I., & Friend, K. (1992) · The Lancet · doi:10.1016/0140-6736(92)92503-8 · Cited by 178
An Ultrasound Renal Cyst Prevalence Survey: Specificity Data for Inherited Renal Cystic Diseases
Ravine, D., Gibson, R. N., Donlan, J., & Sheffield, L. J. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70338-4 · Cited by 169
Bilineal Disease and Trans-Heterozygotes in Autosomal Dominant Polycystic Kidney Disease
Pei, Y., Paterson, A. D., Wang, K. R., He, N., Hefferton, D., Watnick, T., Germino, G. G., Parfrey, P., Somlo, S., & St. George-Hyslop, P. (2001) · The American Journal of Human Genetics · doi:10.1086/318188 · Cited by 163
Genotype-Renal Function Correlation in Type 2 Autosomal Dominant Polycystic Kidney Disease
Magistroni, R., He, N., Wang, K., Andrew, R., Johnson, A., Gabow, P. A., Dicks, E. L., Parfrey, P. S., Torrá, R., San‐Millán, J. L., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000061774.90975.25 · Cited by 157
Roberts, I., Perel, P., Prieto‐Merino, D., Shakur‐Still, H., Coats, T., Hunt, B. J., Lecky, F. E., Brohi, K., Willett, K. M., & collaborators., O. B. O. T. C.-2. (2012) · BMJ · doi:10.1136/bmj.e5839 · Cited by 156
Sundström, A., Seaman, H. E., Kieler, H., & Alfredsson, L. S. (2008) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.01926.x · Cited by 143
Angiogenesis in autosomal-dominant polycystic kidney disease
Bello-Reuss, E. N., Holubec, K., & Rajaraman, S. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00768.x · Cited by 138
Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of trans-heterozygous mutations
Watnick, T. J., He, N., Wang, K., Liang, Y., Parfrey, P. S., Hefferton, D., George‐Hyslop, P. S., Germino, G. G., & Pei, Y. (2000) · Nature Genetics · doi:10.1038/75981 · Cited by 130
A ‘two-hit’ model of cystogenesis in autosomal dominant polycystic kidney disease?
Pei, Y. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)01953-0 · Cited by 127
Rapid MR Imaging Detection of Renal Cysts: Age-based Standards
Nascimento, A. B., Mitchell, D. G., Zhang, X., et al. (2001) · Radiology · doi:10.1148/radiol.2213010178 · Cited by 94
Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease
García-González, M. Á., Jones, J. G., Allen, S. K., Palatucci, C., Batish, S. D., Seltzer, W. K., Lan, Z., Allen, E., Qian, F., Lens, X. M., et al. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.05.004 · Cited by 92
Pharmacologic preservation of the hemostatic system during cardiac surgery
Levy, J. H. (2001) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(01)03218-0 · Cited by 71
Familial phenotype differences in PKD1
Hateboer, N., Lazarou, L., Williams, A. J., Holmans, P., & Ravine, D. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00541.x · Cited by 71
Clinical features of cyst infection and hemorrhage in ADPKD: new diagnostic criteria
Suwabe, T., Ubara, Y., Sumida, K., Hayami, N., Hiramatsu, R., Yamanouchi, M., Hasegawa, E., Hoshino, J., Sawa, N., Saitoh, S., et al. (2012) · Clinical and Experimental Nephrology · doi:10.1007/s10157-012-0650-2 · Cited by 71
Andersson, L. I., Eriksson, O., Hedlund, P. O., Kjellman, H., & Lindqvist, B. (1978) · Urological Research · doi:10.1007/bf00255578 · Cited by 68
Wu, M., Gu, J., Mei, S., Xu, D., Jing, Y., Yao, Q., Chen, M., Yang, M., Chen, S., Yang, B., et al. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw058 · Cited by 62
Self-citationRodríguez, D., Kapoor, S., Edenhofer, I., Segerer, S., Riwanto, M., Kipar, A., Yang, M., Mei, C., & Wuthrich, R. P. (2015) · Kidney & Blood Pressure Research · doi:10.1159/000368540 · Cited by 53
Self-citationDevelopments in the management of autosomal dominant polycystic kidney disease
Schrier, R. W. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s1617 · Cited by 51
Chen, D., Ma, Y., Wang, X., Yu, S., Li, L., Dai, B., Mao, Z., Sun, L., Xu, C., Shu, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092232 · Cited by 42
Self-citationPharmacological management of polycystic kidney disease
Wuthrich, R. P., & Mei, C. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.903923 · Cited by 31
Self-citationPeces, R., Aguilar, A., Vega, C., Cuesta, E., Peces, C., & Selgas, R. (2012) · PubMed · doi:10.3265/nefrologia.pre2011.dec.11210 · Cited by 25
Angiogenesis and autosomal dominant polycystic kidney disease
Huang, J. L., Woolf, A. S., & Long, D. A. (2012) · Pediatric Nephrology · doi:10.1007/s00467-012-2305-7 · Cited by 25
Nature and nurture on phenotypic variability of autosomal dominant polycystic kidney disease
Pei, Y. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00252.x · Cited by 23
Cited by
Rossaint, R., Bouillon, B., Cerny, V., Coats, T. J., Duranteau, J., Fernández-Mondéjar, E., Filipescu, D., Hunt, B. J., Komadina, R., Nardi, G., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1265-x · Cited by 1,484
Spahn, D. R., Bouillon, B., Cerny, V., Duranteau, J., Filipescu, D., Hunt, B. J., Komadina, R., Maegele, M., Nardi, G., Riddez, L., et al. (2019) · Critical Care · doi:10.1186/s13054-019-2347-3 · Cited by 1,269
Management of bleeding and coagulopathy following major trauma: an updated European guideline
Spahn, D. R., Bouillon, B., Cerny, V., Coats, T. J., Duranteau, J., Fernández-Mondéjar, E., Filipescu, D., Hunt, B. J., Komadina, R., Nardi, G., et al. (2013) · Critical Care · doi:10.1186/cc12685 · Cited by 977
Tranexamic Acid: A Review of its Use in the Treatment of Hyperfibrinolysis
McCormack, P. L. (2012) · Drugs · doi:10.2165/11209070-000000000-00000 · Cited by 640
Irazabal, M. V., Rangel, L. J., Bergstralh, E. J., Osborn, S. L., Harmon, A. J., Sundsbak, J. L., Bae, K. T., Chapman, A. B., Grantham, J. J., Mrug, M., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013101138 · Cited by 625
Metadata
- Authors
- Yao, Q., Wu, M., Zhou, J., Zhou, M., Chen, D., Fu, L., Bian, R., Xing, X., Sun, L., Hu, X., Li, L., Dai, B., Wüthrich, R. P., Ma, Y., & Mei, C.-L.
- Venue
- Kidney and Blood Pressure Research
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 42
- Issue
- 1
- Pages
- 156-164
- ISSN
- 1420-4096 (ISSN-L)
- 1423-0143
- OpenAlex
- W2605806871
- Cited by
- 847
- References
- 48
- FWCI
- 47.30
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.